NRAS and melanoma: Mutation status was also significantly associated with the site of the primary tumor (P= 0.004, Chi-square test, Table 2); BRAF and NRAS mutations were relatively more common in melanomas from the trunk (23.6% and 21.0%) compared to tumors without mutations detected (Wild Type) (15.3%).